ExpreS2ion Biotech
ExpreS2ion will present fourth quarter and full-year 2022 results
By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS2 technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each event and how to register is found below and on the Company’s website.
Presentation of fourth quarter and full-year 2022 results hosted by HC Andersen Capital, February 15th, 2023 at 14:30 CET, Virtual
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the fourth quarter and full-year 2022 results and answer investors’ questions. More information and registration can be found on the H.C. Andersen Capital Events website.
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
| Datum | 2023-02-13, kl 16:46 |
| Källa | Cision |
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.